Chemed Corp
NYSE:CHE

Watchlist Manager
Chemed Corp Logo
Chemed Corp
NYSE:CHE
Watchlist
Price: 522.8 USD 0.12% Market Closed
Market Cap: 7.8B USD
Have any thoughts about
Chemed Corp?
Write Note

Chemed Corp
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Chemed Corp
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Chemed Corp
NYSE:CHE
Cost of Revenue
-$1.5B
CAGR 3-Years
-4%
CAGR 5-Years
-4%
CAGR 10-Years
-4%
Quest Diagnostics Inc
NYSE:DGX
Cost of Revenue
-$6.4B
CAGR 3-Years
1%
CAGR 5-Years
-5%
CAGR 10-Years
-4%
CVS Health Corp
NYSE:CVS
Cost of Revenue
-$316.5B
CAGR 3-Years
-10%
CAGR 5-Years
-10%
CAGR 10-Years
-11%
Cigna Corp
NYSE:CI
Cost of Revenue
-$206.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Laboratory Corporation of America Holdings
NYSE:LH
Cost of Revenue
-$9.2B
CAGR 3-Years
4%
CAGR 5-Years
-2%
CAGR 10-Years
-9%
R1 RCM Inc
NASDAQ:RCM
Cost of Revenue
-$2B
CAGR 3-Years
-21%
CAGR 5-Years
-16%
CAGR 10-Years
-27%
No Stocks Found

Chemed Corp
Glance View

Market Cap
7.9B USD
Industry
Health Care
Economic Moat
None

Chemed Corporation, a somewhat enigmatic yet resolutely steadfast entity, operates in the realms of hospice care and plumbing services, a duality that intrigues analysts and investors alike. Established through strategic foresight, Chemed has crafted a remarkably resilient business model by housing two distinct subsidiaries under its corporate umbrella: VITAS Healthcare and Roto-Rooter. VITAS Healthcare, which still stands as the nation's largest provider of end-of-life care, dominates the hospice sector by offering comprehensive palliative care services right at the patients' doorstep, aiming to ensure dignity and comfort during life's final stages. This subsidiary capitalizes on a combination of Medicare and Medicaid reimbursements as well as private insurances, which form the backbone of its revenue stream. Meanwhile, Roto-Rooter, a company with a name synonymous with plumbing repair and maintenance, fortifies Chemed's revenue streams through an entirely different channel. Known as a household name across America, Roto-Rooter offers an extensive range of services from emergency plumbing repair to water cleanup and restoration. With its franchise model combined with company-operated branches, Roto-Rooter generates income primarily through service fees. The dual nature of Chemed’s operational style—a blend of healthcare sensitivity and industrial pragmatism—not only ensures diversified income avenues but also exemplifies a pragmatic approach to risk management. This business strategy, deftly combining distinct yet robust sectors, allows Chemed to weather economic fluctuations that might impact one industry but not the other, ultimately creating a stable financial foundation for the company.

CHE Intrinsic Value
495.79 USD
Overvaluation 5%
Intrinsic Value
Price

See Also

What is Chemed Corp's Cost of Revenue?
Cost of Revenue
-1.5B USD

Based on the financial report for Sep 30, 2024, Chemed Corp's Cost of Revenue amounts to -1.5B USD.

What is Chemed Corp's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-4%

Over the last year, the Cost of Revenue growth was -5%. The average annual Cost of Revenue growth rates for Chemed Corp have been -4% over the past three years , -4% over the past five years , and -4% over the past ten years .

Back to Top